Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications
- 1 June 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Neurology
- Vol. 24 (3), 224-229
- https://doi.org/10.1097/wco.0b013e328346056f
Abstract
Multiple sclerosis (MS) treatments targeting the inflammatory nature of the disease have become increasingly effective in recent years. However, our efforts at targeting the progressive disease phase have so far been largely unsuccessful. This has led to the hypothesis that disease mechanisms independent of an adaptive immune response contribute to disease progression and closely resemble neurodegeneration. Nonfocal, diffuse changes in the MS brain, especially axonal loss and mitochondrial dysfunction, prove better correlates of disability than total lesion load and have been associated with disease progression. Molecular changes in nondemyelinated MS tissue also suggest that alterations in the MS brain are widespread and consist of pro-inflammatory as well as anti-inflammatory responses. However, local lymphocytic inflammation and microglial activation are salient features of the chronic disease, and T-cell-mediated inflammation contributes to tissue damage. In addition, neuroaxonal cytoskeletal alterations have been associated with disease progression. Our knowledge of the molecular mechanisms leading to neuroaxonal damage and demise in MS is steadily increasing. Experimental therapies targeting neuroaxonal ionic imbalances and energy metabolism in part show promising results. A better understanding of the molecular mechanisms underlying chronic progression will substantially aid the development of new treatment strategies.Keywords
This publication has 63 references indexed in Scilit:
- Mechanisms of neuronal dysfunction and degeneration in multiple sclerosisProgress in Neurobiology, 2011
- Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulationTrends in Molecular Medicine, 2010
- Mechanisms of acute axonal degeneration in the optic nerve in vivoProceedings of the National Academy of Sciences of the United States of America, 2010
- Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAELaboratory Investigation, 2010
- HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damageNature Neuroscience, 2009
- Silencing Nogo-A promotes functional recovery in demyelinating diseaseAnnals of Neurology, 2009
- The relation between inflammation and neurodegeneration in multiple sclerosis brainsBrain, 2009
- Mitochondrial changes within axons in multiple sclerosisBrain, 2009
- Phosphorylation and compactness of neurofilaments in multiple sclerosis: Indicators of axonal pathologyExperimental Neurology, 2008
- MRI in multiple sclerosis: current status and future prospectsThe Lancet Neurology, 2008